Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
5 resultat
Ketone esters for treatment of angelman syndrome
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Angelman Syndrome (AS) is a devastating neurological disorder with a prevalence of 1 in 15,000 that currently has no cure. AS presents with ataxia, frequent smiling, and laughter, lack of speech, and severe, debilitating seizures. Epilepsy in AS is often refractory to
Ketone supplements for treatment of angelman syndrome
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Angelman Syndrome (AS) is a devastating neurological disorder with a prevalence of 1 in 15,000 that currently has no cure. AS presents with ataxia, frequent smiling, and laughter, lack of speech, and severe, debilitating seizures. Epilepsy in AS is often refractory to
5-phenyl-2-furan ketones and use as antiepileptic agents
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
This invention relates to certain novel 5-phenyl-2-furan ketones useful as antiepileptic agents.
Antiepileptic agents are used to treat seizure disorders. Approximately 2.5 million of all Americans have epilepsy. Epilepsy often begins in childhood, with three quarters of
Compounds for the treatment of seizures and other central nervous systems disorders and conditions
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
The present application relates to novel compounds comprising a moiety that leads to the metabolic production of ketones bonded to a ketone-potentiated anti-epileptic drug, compositions comprising these compounds, and their use, for example for the treatment of epilepsy, seizures, and/or other
Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
The present invention is generally in the field of nutritional and therapeutic compositions for the modulation of ketone levels in humans and other mammals.
There are a number of conditions in human and animals in which it is desirable to increase the levels of ketone
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
